All In MedTech

Device Trial Radar · NCT07926009

NAVA Use in Preterm Neonates With Respiratory Distress Syndrome

Neurally Adjusted Ventilatory Assist [NAVA] Versus Conventional Ventilation in Preterm Neonates With Respiratory Distress Syndrome

Last checked: Nov 19, 2026Latest source record: Nov 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Jan 24, 2026

Primary completion

Oct 2027

Study completion Jan 2028

Sponsor

Lead sponsor
Ain Shams UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 9, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Diagnostic
FDA-regulated device
No
Who can join
All sexes, from 1 day, up to 1 month
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A randomized controlled clinical trial evaluates the efficacy of NAVA in comparison with conventional ventilation (SIMV) in preterm neonates with respiratory distress syndrome.

Conditions

  • Preterm , Respiratory Distress Syndrome
  • Preterm Respiratory Distress Syndrome

Interventions

  • Maquet [servo-n]Device

    ventilator settings will be recorded such as: NAVA level , Edi peak , peep, apnea time

  • Drager , SLE 5000, SLE 6000Device

    ventilator settings will be recorded such as peep , PIP , Fio2

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. EchocardiographyTime frame: baseline and after 24 hours from enrollment in the study

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Neonatal Intensive Care Units (NICUs), Ain Shams University

    Cairo, Abbasia, Egypt · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.